 |
|
Antibiotics: EUR13 million to step up EU research on antibiotic resistance
November 27, 2003Today 200 scientists meet in Rome at the EU conference on "The Role of Research in Combating Antibiotic Resistance". It was organised by the European Commission together with the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).
Antibiotics, once hailed as a panacea to combat bacterial infections, seem to be more and more ineffective. The human body is responding less and less to antibiotics. New, more dangerous diseases, stubbornly resisting their power, are developing.
The aim of the conference is to identify future research priorities to tackle the problem of anti-bacterial resistance and human health, addressing both basic and clinical research. At the same time, the Commission is announcing that it will invest EUR6 million to support two major research projects in this field, with a total project budget of EUR12.6 million from the first call for proposals in the Sixth Research Framework Programme (2002-2006).
One of these projects looks into resistance to the major class of antibiotics in clinical use, while the other project investigates basic molecular mechanisms of resistance. The projects are being negotiated and will start in a few weeks after signing of contracts.
"People trust antibiotics to cure almost any kind of disease: unfortunately, as recent outbreaks of Severe Acute Respiratory Syndrome (SARS) show, this is not the case," says European Research Commissioner Philippe Busquin.
"Antibiotic resistance is therefore the focus of research within the EU scientific funding programmes. More research for the benefit of patients is needed to make use of the wealth of information provided by more than 140 bacterial genomes known today. We must also make sure that the pharmaceutical industry continues its research into the development of new antibiotics. With more than EUR100 million invested by the EU over the last four years in this field, we have supported more than 80 research projects on antimicrobial resistance. We will keep up the fight to find innovative answers to this problem."
Once "wonder drugs" ineffective today
Infectious diseases have the potential, like no other group of diseases, to spread rapidly over large distances in a short time. If no effective tools for treatment and prevention are available, they can dramatically change the lives of people and destabilise societies. The first antibiotic drugs became available in the wake of the Second World War, to save soldiers from deadly wounds. These powerful drugs soon became known as "wonder drugs" and were generously prescribed against minor bacterial infections or even viral infections, against which they have never been effective. Today, we pay the price for this complacency. In a recent Eurobarometer survey, Europeans were asked about their 'antibiotic habits': 38% of EU citizens had taken antibiotics in the last 12 months (45% of French and Spaniards but only 22% of Danes) out of whom 93% had a prescription.
Due to overuse and mis-use of these drugs, bacterial resistance to antibiotics is now accelerating at a disturbing rate worldwide. Previously effective antibiotics have lost their powers against a steadily growing list of resistant pathogens. As a result, the arsenal against severe, and often lethal, infectious diseases, like tuberculosis and pneumonia is rapidly diminishing.
Are pharmaceutical companies reluctant to invest in research?
Many pharmaceutical companies have pulled out from investments into research on new antimicrobial drugs. The expected sales revenues are no longer sufficient to make up for the costs linked to the development of these drugs. Many companies have instead refocused their efforts on the more profitable treatments for chronic diseases rather than short-course therapies for infections. This has contributed to making the situation worse.
Research needs
On the other hand, considerable progress has been made in recent years to address these problems thanks to gene technology. Today, more than 140 bacterial genomes are known. However, knowledge of the genetic code of an organism does not in itself generate new drugs. In the light of these developments, plans for how to make the most of European-led research in the fight against antibiotic resistance need to be drawn up. Scientists from various related disciplines will discuss some of the more burning issues at the Antibiotic Resistance conference in Rome from 28-30 November. A report and results will be published after the conference.
New research projects to be launched
Two research projects emerging from the first call for proposals on antibiotic resistance will start their work in early 2004 after signing of contracts. Both aim at a better understanding of fundamental mechanisms of resistance, which will be a necessity for future drug development.
One of these projects will look into how resistance to the major class of antibiotics in clinical use, the ?-lactam antibiotics, arises in some of the most severe hospital and community-spread infections.
The second project also looks at basic molecular mechanisms of resistance, but here the focus is specifically on Streptococcus pneumoniae, for two reasons. The first is that it is the major cause of life-threatening pneumonia, septicaemia and meningitis. The other is that it is also the major cause of milder upper respiratory tract infections and large amounts of antibiotics are therefore consumed every year to treat these infections. The project will study how the bacteria manage to survive, grow and spread in the presence of an antibiotic and what factors determine whether an infection will be mild or severe.
Both projects were selected from the first call for proposals addressing various topics of antimicrobial resistance within the EU Sixth Research Framework Programme and will be presented in more detail in Rome. Three further calls will continue to strengthen the European Research Area on antimicrobial resistance research.
European Commission, Research Directorate
Bacteria Current Events and Bacteria News RSSNovel bioreactor enhances interleukin-12 production in genetically-modified tobacco plants
Interleukin-12 is a naturally occurring protein essential for the proper functioning of the human immune system.
Researchers identify cell group key to Lyme disease arthritis
A research team led by the La Jolla Institute for Allergy & Immunology and Albany Medical College has illuminated the important role of natural killer (NK) T cells in Lyme disease, demonstrating that the once little understood white blood cells are central to clearing the bacterial infection and reducing the intensity and duration of arthritis associated with Lyme disease.
Blood tests can help detect presence of necrotizing soft tissue infections
With less than half of patients with necrotizing soft tissue infections displaying the physical signs of these very serious infections, researchers have found two simple blood tests can help physicians diagnose what is commonly known as "flesh-eating bacteria," according to a study in the December issue of The American Journal of Surgery.
Vaccine and drug research aimed at ticks and mosquitoes to prevent disease transmission
Most successful vaccines and drugs rely on protecting humans or animals by blocking certain bacteria from growing in their systems. But, a new theory actually hopes to take stopping infectious diseases such as West Nile virus and Malaria to the next level by disabling insects from transmitting these viruses.
Research in twins defines shared features of the human gut microbial communities: variations linked to obesity
Trillions of microbes make their home in the gut, where they help to break down and extract energy and nutrients from the food we eat. Yet, scientists have understood little about how this distinctive mix of microbes varies from one individual to the next.
Rivers are carbon processors, not inert pipelines
Microorganisms in rivers and streams play a crucial role in the global carbon cycle that has not previously been considered.
Vitamin D found to fight placental infection
In a paper available at the online site of the journal Biology of Reproduction, a team of UCLA researchers reports for the first time that vitamin D induces immune responses in placental tissues by stimulating production of the antimicrobial protein cathelicidin.
CSHL scientists discover a new way in which epigenetic information is inherited
Hereditary information flows from parents to offspring not just through DNA but also through the millions of proteins and other molecules that cling to it.
Researchers identify how binge drinking may drive heart disease
As the holidays arrive, a group of researchers has identified the precise mechanisms by which binge drinking contributes to clogs in arteries that lead to heart attack and stroke, according to a study published today in the journal Atherosclerosis.
Researchers identify new leprosy bacterium
A new species of bacterium that causes leprosy has been identified through intensive genetic analysis of a pair of lethal infections, a research team reports in the December issue of the American Journal of Clinical Pathology.
More Bacteria Current Events and Bacteria News Articles
 | A Field Guide to Bacteria (Comstock Book) by Betsey Dexter Dyer Pocket-guide to observing bacteria without a laboratory or fancy equipment. Presents all the major taxonomic groups of bacteria in a useable, accessible format for amateur naturalists who may or may not have access to a microscope. Includes ideas for planning field trips to explore bacteria in their natural environments. Illustrated, some color. Softcover, hardcover... |
 | The Killers Within: The Deadly Rise of Drug-Resistant Bacteria by Michael Shnayerson, Mark J. Plotkin A battle is taking place on the frontiers of medicine between rapidly evolving bacteria that threaten our health and the doctors who are struggling to outwit them. These bacteria are everywhere: in and on our bodies, in homes, schools, hospitals, crowded airplaines, day-care centers. And, as THE KILLERS WITHIN makes frighteningly clear, so far the bacteria are... |
 | Bacteria for Breakfast: Probiotics for Good Health by Kelly Dowhower Karpa, PhD, RPh Although in Western society the beneficial aspects of bacteria have been increasingly minimized, we actually need bacteria in our digestive tracts for good health. This resource explains, to laymen and physicians, how probiotics support immune function, prevent urogenital infections, and maintain good gastrintestinal... |
 | Molecular Genetics of Bacteria (Snyder, Molecular Genetics of Bacteria) by Larry Snyder, Wendy Champness This landmark volume provides the single most comprehensive and authoritative textbook on bacterial molecular genetics. Perfect for advanced undergraduate and graduate-level courses, the text presents the latest research on the subject in a clearly written and well-illustrated style. It provides descriptive background information, detailed experimental methods, examples of genetic analyses, and... |
 | Prentice Hall Science Explorer: From Bacteria to Plants by Michael J. Padilla, Ioannis Miaoulis, Martha Cyr |
 | Science Explorer from Bacteria to Plants (Prentice Hall science explorer) |
 | Respiration in Archaea and Bacteria: Diversity of Prokaryotic Respiratory Systems (Advances in Photosynthesis and Respiration) The book summarizes the achievements of the past decade in the biochemistry, bioenergetics, structural and molecular biology of respiratory processes in selected genera of the domain Bacteria along with an extensive coverage of the redox chains of extremophiles belonging to the Archaean domain. The volume is a unique piece of work since it contains a series of chapters dealing with metabolic... |
 | The Five-Second Rule and Other Myths About Germs: What Everyone Should Know About Bacteria, Viruses, Mold, and Mildew by Anne E. Maczulak |
 | Why Size Matters: From Bacteria to Blue Whales by John Tyler Bonner John Tyler Bonner, one of our most distinguished and creative biologists, here offers a completely new perspective on the role of size in biology. In his hallmark friendly style, he explores the universal impact of being the right size. By examining stories ranging from Alice in Wonderland to Gulliver's Travels, he shows that humans have always been fascinated by things big and small. Why then... |
 | Herbal Antibiotics: Natural Alternatives for Treating Drug-Resistant Bacteria (Storey Medicinal Herb Guide) by Stephen Harrod Buhner Current information about antibiotic resistant microbes and the herbs that are effective in fighting... |
| © 2008 BrightSurf.com |